ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 3, Pages 903
Publisher
MDPI AG
Online
2020-01-31
DOI
10.3390/ijms21030903
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy
- (2019) Wanxia Gai et al. Genes
- A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
- (2019) Begoña Pineda et al. Clinical Epigenetics
- Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?
- (2019) Fiorella Calabrese et al. Journal of Clinical Medicine
- Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic Subtypes
- (2019) Maggie L. DiNome et al. ANNALS OF SURGICAL ONCOLOGY
- TSPAN9 and EMILIN1 synergistically inhibit the migration and invasion of gastric cancer cells by increasing TSPAN9 expression
- (2019) Yaoyue Qi et al. BMC CANCER
- Epigenetic IVD Tests for Personalized Precision Medicine in Cancer
- (2019) Jesús Beltrán-García et al. Frontiers in Genetics
- The Different Facets of Liquid Biopsy: A Kaleidoscopic View
- (2019) Zahra Eslami-S et al. Cold Spring Harbor Perspectives in Medicine
- An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis
- (2018) Man-Li Luo et al. CANCER LETTERS
- Novel prognostic and predictive microRNA targets for triple-negative breast cancer
- (2018) Gulisa Turashvili et al. FASEB JOURNAL
- URG11 Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion
- (2018) Bin Pan et al. Biomed Research International
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic and Predictive Epigenetic Biomarkers in Oncology
- (2018) Katarzyna Kamińska et al. Molecular Diagnosis & Therapy
- ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy
- (2018) V. L. Veenstra et al. Oncogenesis
- Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer
- (2017) Sara Duhachek-Muggy et al. Molecular Cancer
- ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling
- (2017) Roopali Roy et al. MOLECULAR CANCER RESEARCH
- CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
- (2017) Esperanza Martin-Sanchez et al. Oncotarget
- Methylation patterns in serum DNA for early identification of disseminated breast cancer
- (2017) Martin Widschwendter et al. Genome Medicine
- CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
- (2017) Esperanza Martín-Sánchez et al. Clinical Epigenetics
- ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells
- (2017) Xuedong Wang et al. Scientific Reports
- A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients
- (2016) Yu Gui et al. Biomarkers in Medicine
- Epigenetic field cancerization in gastrointestinal cancers
- (2016) Yoshifumi Baba et al. CANCER LETTERS
- Tspan9 inhibits the proliferation, migration and invasion of human gastric cancer SGC7901 cells via the ERK1/2 pathway
- (2016) PAI-YUN LI et al. ONCOLOGY REPORTS
- Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients
- (2016) Eva Jezkova et al. TUMOR BIOLOGY
- Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer
- (2016) Ming Shan et al. Oncotarget
- DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients
- (2016) Andrea Mathe et al. Scientific Reports
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- Field cancerisation in colorectal cancer: A new frontier or pastures past?
- (2015) Abhilasha Patel WORLD JOURNAL OF GASTROENTEROLOGY
- Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value
- (2015) Clare Stirzaker et al. Nature Communications
- The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition
- (2015) Michaël Ruff et al. PLoS One
- Multifocal epithelial tumors and field cancerization: stroma as a primary determinant
- (2014) G. Paolo Dotto JOURNAL OF CLINICAL INVESTIGATION
- Prognostic and Predictive Biomarkers in Adult and Pediatric Gliomas: Toward Personalized Treatment
- (2014) Harry R. Haynes et al. Frontiers in Oncology
- Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype
- (2013) Hui Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Neoadjuvant treatment for HER-2-positive and triple-negative breast cancers
- (2012) B. Sousa et al. ANNALS OF ONCOLOGY
- An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer
- (2012) Hui Li et al. BREAST CANCER RESEARCH AND TREATMENT
- CST6 promoter methylation in circulating cell-free DNA of breast cancer patients
- (2012) Maria Chimonidou et al. CLINICAL BIOCHEMISTRY
- Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients
- (2011) Georg Göbel et al. BREAST CANCER RESEARCH AND TREATMENT
- CpG islands and the regulation of transcription
- (2011) A. M. Deaton et al. GENES & DEVELOPMENT
- ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth
- (2011) Roopali Roy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ADAM12 Produced by Tumor Cells Rather than Stromal Cells Accelerates Breast Tumor Progression
- (2011) C. Frohlich et al. MOLECULAR CANCER RESEARCH
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
- (2009) Pierre Farmer et al. NATURE MEDICINE
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More